Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.
van der Kruijssen DEW, Elias SG, van de Ven PM, van Rooijen KL, Lam-Boer J', Mol L, Punt CJA, Sommeijer DW, Tanis PJ, Nielsen JD, Yilmaz MK, van Riel JMGH, Wasowiz-Kemps DK, Loosveld OJL, van der Schelling GP, de Groot JWB, van Westreenen HL, Jakobsen HL, Fromm AL, Hamberg P, Verseveld M, Jaensch C, Liposits GI, van Duijvendijk P, Oulad Hadj J, van der Hoeven JAB, Trajkovic M, de Wilt JHW, Koopman M; CAIRO4 Working Group. van der Kruijssen DEW, et al. Among authors: van der schelling gp. Ann Oncol. 2024 Sep;35(9):769-779. doi: 10.1016/j.annonc.2024.06.001. Epub 2024 Jun 7. Ann Oncol. 2024. PMID: 38852675 Free article. Clinical Trial.
The Difficulty of Detecting Occult Metastases in Patients with Potentially Resectable Pancreatic Cancer: Development and External Validation of a Preoperative Prediction Model.
Walma M, Maggino L, Smits FJ, Borggreve AS, Daamen LA, Groot VP, Casciani F, de Meijer VE, Wessels FJ, van der Schelling GP, Nieuwenhuijs VB, Bosscha K, van der Harst E, van Dam R, Liem MS, Festen S, Stommel MWJ, Roos D, Wit F, de Hingh IH, Bonsing BA, Busch OR, Groot Koerkamp B, Kazemier G, Besselink MG, Salvia R, Malleo G, Molenaar IQ, van Santvoort HC; Dutch Pancreatic Cancer Group. Walma M, et al. Among authors: van der schelling gp. J Clin Med. 2024 Mar 14;13(6):1679. doi: 10.3390/jcm13061679. J Clin Med. 2024. PMID: 38541904 Free PMC article.
Early experience with robotic pancreatoduodenectomy versus open pancreatoduodenectomy: nationwide propensity-score-matched analysis.
de Graaf N, Zwart MJW, van Hilst J, van den Broek B, Bonsing BA, Busch OR, Coene PLO, Daams F, van Dieren S, van Eijck CHJ, Festen S, de Hingh IHJT, Lips DJ, Luyer MDP, Mieog JSD, van Santvoort HC, van der Schelling GP, Stommel MWJ, de Wilde RF, Molenaar IQ, Groot Koerkamp B, Besselink MG. de Graaf N, et al. Among authors: van der schelling gp. Br J Surg. 2024 Jan 31;111(2):znae043. doi: 10.1093/bjs/znae043. Br J Surg. 2024. PMID: 38415878 Free PMC article.
Long-term follow-up study of necrotising pancreatitis: interventions, complications and quality of life.
Hollemans RA, Timmerhuis HC, Besselink MG, Bouwense SAW, Bruno M, van Duijvendijk P, van Geenen EJ, Hadithi M, Hofker S, Van-Hooft JE, Kager LM, Manusama ER, Poley JW, Quispel R, Römkens T, van der Schelling GP, Schwartz MP, Spanier BWM, Stommel M, Tan A, Venneman NG, Vleggaar F, van Wanrooij RLJ, Bollen TL, Voermans RP, Verdonk RC, van Santvoort HC; Dutch Pancreatitis Study Group. Hollemans RA, et al. Among authors: van der schelling gp. Gut. 2024 Apr 5;73(5):787-796. doi: 10.1136/gutjnl-2023-329735. Gut. 2024. PMID: 38267201
Nationwide validation of the distal fistula risk score (D-FRS).
van Bodegraven EA, den Haring FET, Pollemans B, Monselis D, De Pastena M, van Eijck C, Daams F, de Hingh I, Luyer M, Stommel MWJ, van Santvoort HC, Festen S, Mieog JSD, Klaase J, Lips D, Coolsen MME, van der Schelling GP, Manusama ER, Patijn G, van der Harst E, Bosscha K, Marchegiani G, Besselink MG. van Bodegraven EA, et al. Among authors: van der schelling gp. Langenbecks Arch Surg. 2023 Dec 20;409(1):14. doi: 10.1007/s00423-023-03192-w. Langenbecks Arch Surg. 2023. PMID: 38114826
Uptake of robot-assisted colon cancer surgery in the Netherlands.
Sterk MFM, Crolla RMPH, Verseveld M, Dekker JWT, van der Schelling GP, Verhoef C, Olthof PB. Sterk MFM, et al. Among authors: van der schelling gp. Surg Endosc. 2023 Nov;37(11):8196-8203. doi: 10.1007/s00464-023-10383-5. Epub 2023 Aug 29. Surg Endosc. 2023. PMID: 37644155 Free PMC article.
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials.
Doppenberg D, van Dam JL, Han Y, Bonsing BA, Busch OR, Festen S, van der Harst E, de Hingh IH, Homs MYV, Kwon W, Lee M, Lips DJ, de Meijer VE, Molenaar IQ, Nuyttens JJ, Patijn GA, van Roessel S, van der Schelling GP, Suker M, Versteijne E, de Vos-Geelen J, Wilmink JW, van Eijck CHJ, van Tienhoven G, Jang JY, Besselink MG, Groot Koerkamp B; Dutch Pancreatic Cancer Group. Doppenberg D, et al. Among authors: van der schelling gp. Br J Surg. 2023 Sep 6;110(10):1374-1380. doi: 10.1093/bjs/znad210. Br J Surg. 2023. PMID: 37440421 Free PMC article.
Nationwide use and Outcome of Minimally Invasive Distal Pancreatectomy in IDEAL Stage IV following a Training Program and Randomized Trial.
Korrel M, van Hilst J, Bosscha K, Busch ORC, Daams F, van Dam R, van Eijck CHJ, Festen S, Groot Koerkamp B, van der Harst E, Lips DJ, Luyer MD, de Meijer VE, Mieog JSD, Molenaar IQ, Patijn GA, van Santvoort HC, van der Schelling GP, Stommel MWJ, Besselink MG; Dutch Pancreatic Cancer Group. Korrel M, et al. Among authors: van der schelling gp. Ann Surg. 2024 Feb 1;279(2):323-330. doi: 10.1097/SLA.0000000000005900. Epub 2023 May 4. Ann Surg. 2024. PMID: 37139822 Clinical Trial.
Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX - The LAPC-2 trial.
van 't Land FR, Latifi D, Moskie M, Homs MYV, Bosscha K, Bonsing BA, Mieog SD, van der Harst E, Coene PLO, Wijsman JH, van der Schelling GP, Groot Koerkamp B, Nuyttens JJ, van Eijck CHJ; South West Pancreatic Cancer Care SWPCC consortium. van 't Land FR, et al. Among authors: van der schelling gp. Radiother Oncol. 2023 Jun;183:109541. doi: 10.1016/j.radonc.2023.109541. Epub 2023 Feb 20. Radiother Oncol. 2023. PMID: 36813171 Clinical Trial.
60 results